Numerous proteinic and other drugs designed to target diverse cellular processes have appeared in recent years, necessitating the development of intelligent drug delivery systems that can detect and respond to pathophysiological circumstances directly. Traditional small molecules and current large molecules are frequently focused at cell surface targets or supplied without a precise molecular-targeting strategy; however, these prospective novel therapies are different. As a result, advanced drug delivery systems are required for the targeted and regulated release of unique compounds in tissues and cells in order to maximize their potential patient advantages. The term "advanced drug delivery system" refers to a system that improves drug potency, regulates drug release for a longer-lasting therapeutic effect, and increases safety, before eventually targeting a drug to the appropriate tissue.
Title : Innate Immune memory based therapeutics in the resolution of inflammation
Liwu Li, Virginia Polytechnic Institute and State University, United States
Title : Drugs as an environmental problem chromatographic and computational studies of drugs partition between soil and water
Anna Weronika Sobanska, Medical University of Lodz, Poland
Title : Resveratrol derivatives a new tool for osteogenic induction in the treatment of peri implantitis
Barbara De Filippis, University “G. d’Annunzio, Italy
Title : Comparative Study on Inhibition of Pancreatic Cancer Cells by Resveratrol Gold Nanoparticle and Resveratrol Nanoemulsion Prepared from Grape Skin
Bing Huei Chen, Fu Jen Catholic University, Taiwan
Title : Adiposome a Hydrophobic Drug Delivery System
Pingsheng Liu, Chinese Academy of Sciences, China
Title : Targeting breast cancer through prodrug activation by cytochrome P450 1A1
Sebastien Fortin, Laval University, Canada